Efficacy and CNS results from a randomized subset of the phase 2 SAVANNAH study comparing savolitinib (savo) + osimertinib (osi) combination with savo + placebo (PBO).Benjamin Levy, Myung‐Ju Ahn, Adrian G. Sacher et al.|Journal of Clinical Oncology|2025Cited by 4